S-Patch Trial

Country
New Zealand
Sustainable development goals
  • Good health and well-being
Project link
https://www.stuff.co.nz/national/health/89727636/middlemore-hospital-trialling-a-new-heart-monitor-device

About the project

Samsung Healthcare trialed its S-Patch electrocardiogram (ECG) monitoring devise at South Auckland’s Middlemore Hospital in 2017. The small 8-gram wearable S-Patch monitor is used to assess arrhythmia, with AI employed to translate and assess the mass of data collected by the device.

More project information

The healthcare division of global technology giant Samsung chose a New Zealand hospital for a trial of an electrocardiogram monitoring device linked to AI-based data monitoring. Samsung Healthcare trialed its S-Patch electrocardiogram (ECG) monitoring devise at South Auckland’s Middlemore Hospital in 2017. The small 8-gram wearable S-Patch monitor is used to assess arrhythmia, with AI employed to translate and assess the mass of data collected by the device. The S-Patch attaches to the chest via two electrode stickers, and the information is sent to the S-Patch’s built-in bio-processor which is able to measure a patient’s ECG skin temperature, GSR, and body fat. This data is then sent to the patient’s phone, tablet or computer. Arrhythmia is a heart condition where beats are irregular, meaning that they are often either too common or missed. With a 200-patient long waiting list to access Middlemore’s present Holter monitors used for arrhythmia monitoring, the S-Patch allowed more people access to a key piece of healthcare technology. 

Combining wearable sensors with AI diagnostic capabilities is a growing research focus aimed at improving health outcomes. The trial directly supports Good Health and Well-being goal by preventing mortality from non-communicable disease by improving diagnostics and monitoring.